Vai al contenuto

Interazioni tra farmaci

Efgartigimod / hyaluronidase sc + Galcanezumab

Gravità: Moderata

Efgartigimod / hyaluronidase sc and Galcanezumab: moderate interaction.

Ultimo aggiornamento

Per operatori sanitari — solo a scopo di riferimento. Questa pagina è una sintesi breve, non è un parere medico e non sostituisce il RCP ufficiale né il giudizio clinico. Verificare sempre prima di prescrivere o dispensare.

Il contenuto clinico di questa pagina è disponibile solo in inglese.

Sintesi

Efgartigimod blocks the neonatal Fc receptor, which normally recycles IgG and prolongs its half-life. Galcanezumab is an IgG4 antibody, so exposure and migraine prevention could be reduced. Clinical data for the combination are lacking.

Cosa significa questa interazione in parole semplici

Efgartigimod / hyaluronidase sc and Galcanezumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Livello di evidenza: Low

Perché avviene

FcRn blockade by efgartigimod accelerates degradation of IgG-based antibodies such as galcanezumab.

Cosa fare

Monitor migraine frequency and consider an alternative non-antibody preventive if control worsens. Review the need for continued galcanezumab during efgartigimod therapy.

Cosa chiedere al farmacista

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Per gli utenti Pro+

Sblocca la pagina completa

Crei un account e avvii una prova di Pro+ per sbloccare le indicazioni complete sulla gestione di Efgartigimod / hyaluronidase sc e Galcanezumab, le note aggiuntive, il dettaglio delle evidenze e il controllo delle interazioni per un'intera prescrizione.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Provi Pro+ gratis per 14 giorni sul web. Nessuna carta.

Domande frequenti

Can I take Efgartigimod / hyaluronidase sc with Galcanezumab?

MediHelp rates the interaction as moderate. Efgartigimod / hyaluronidase sc and Galcanezumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Efgartigimod blocks the neonatal Fc receptor, which normally recycles IgG and prolongs its half-life. Galcanezumab is an IgG4 antibody, so exposure and migraine prevention could be reduced. Clinical data for the combination are lacking.

How serious is the interaction between Efgartigimod / hyaluronidase sc and Galcanezumab?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor migraine frequency and consider an alternative non-antibody preventive if control worsens. Review the need for continued galcanezumab during efgartigimod therapy.

What other medicines interact with Galcanezumab?

MediHelp also lists interactions of Galcanezumab with, for example, Efgartigimod alfa, Rozanolixizumab. The full list is on the Galcanezumab page.

Monografie complete, posologie e verifica delle interazioni nell'app MediHelp

Apra il riferimento completo, verifichi le interazioni tra più farmaci e usi gli strumenti di posologia nell'app MediHelp.

Sfoglia dalla A alla Z · Interazioni tra farmaci

Scarica l'app Accedi